FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083963888> ?p ?o ?g. }

• W2083963888 endingPage "904" @default.
• W2083963888 startingPage "899" @default.
• W2083963888 abstract "The natural history of heart failure is one of continued worsening of cardiac function. Beta-receptor blocker therapy has been effective in improving clinical status and left ventricular function in patients with heart failure. Similarly, high doses of angiotensin-converting enzyme (ACE) inhibitors with nitrates partially reverse the ventricular remodeling of heart failure.We tested the hypothesis that beta-blocker therapy added to high-dose ACE inhibitor-nitrates would potentiate the reversal of heart failure.Thirteen patients, aged 52 +/- 8 years, with moderate to severe heart failure, 12 of whom were referred for transplant consideration, with heart failure duration of 4.8 +/- 2.2 years, were prospectively followed for 12 months. Baseline echocardiographic ejection fraction was 19 +/- 8%, and presenting New York Heart Association class was 2.9 +/- 0.7. Angiotensin-converting enzyme inhibitors and nitrates were uptitrated over 6 months to a final dose of lisinopril 53 +/- 31 mg/day, and isosorbide dinitrate 217 +/- 213 mg/day. At 6 months, beta-blocker therapy with atenolol was initiated and titrated to a final dose of 46 +/- 23 mg/day. Two-dimensional Doppler echocardiography and metabolic stress testing were performed at baseline, at 6 months on lisinopril-nitrates only, and at 12 months on combined ACE inhibitor-nitrate and beta-blocker therapy.New York Heart Association classification improved from 2.9 +/- 0.7 to 1.8 +/- 0.8 on lisinopril-nitrates (p < 0.05), and to 1.5 +/- 0.5 with the addition of beta blockade (p = NS). On follow-up, peak oxygen consumption rose from 17 +/- 7 ml O2/kg/min at baseline to 21 +/- 5 ml O2/kg/min at 6 months on lisinopril-nitrates (p = 0.06) without further change on beta blockade. Ejection fraction rose from 19 +/- 8 to 33 +/- 14% on lisinopril-nitrates at 6 months (p = 0.005) and to 36 +/- 18% on beta blockade at 12 months (p = NS).High-dose ACE inhibitor-nitrate therapy significantly improved patient clinical status and left ventricular systolic function in heart failure. The addition of beta-receptor blockade over and above high-dose ACE inhibitor-nitrates was well tolerated but had no further impact on symptomatic status, exercise tolerance, or left ventricular systolic function. The potential for pharmacologic reversal of heart failure remodeling may be finite despite the use of complementary therapies. Larger placebo-controlled and randomized trials of beta-receptor blockade added to high-dose ACE inhibitor-nitrate therapy are needed to confirm these observations." @default.
• W2083963888 created "2016-06-24" @default.
• W2083963888 creator A5020150758 @default.
• W2083963888 creator A5065161269 @default.
• W2083963888 creator A5065605818 @default.
• W2083963888 creator A5075323311 @default.
• W2083963888 date "1998-12-01" @default.
• W2083963888 modified "2023-09-27" @default.
• W2083963888 title "The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure" @default.
• W2083963888 cites W1811184201 @default.
• W2083963888 cites W1971540834 @default.
• W2083963888 cites W1977240096 @default.
• W2083963888 cites W1986644699 @default.
• W2083963888 cites W1989431850 @default.
• W2083963888 cites W1992540995 @default.
• W2083963888 cites W1998440385 @default.
• W2083963888 cites W2004923834 @default.
• W2083963888 cites W2008125380 @default.
• W2083963888 cites W2018657443 @default.
• W2083963888 cites W2023044098 @default.
• W2083963888 cites W2024581871 @default.
• W2083963888 cites W2033713778 @default.
• W2083963888 cites W2034463328 @default.
• W2083963888 cites W2040493907 @default.
• W2083963888 cites W2044299579 @default.
• W2083963888 cites W2046383587 @default.
• W2083963888 cites W2048292033 @default.
• W2083963888 cites W2066034228 @default.
• W2083963888 cites W2066920501 @default.
• W2083963888 cites W2072427719 @default.
• W2083963888 cites W2078395346 @default.
• W2083963888 cites W2081536241 @default.
• W2083963888 cites W2086665066 @default.
• W2083963888 cites W2092266587 @default.
• W2083963888 cites W2095308849 @default.
• W2083963888 cites W2123696429 @default.
• W2083963888 cites W2151644209 @default.
• W2083963888 cites W2157973908 @default.
• W2083963888 cites W2168029143 @default.
• W2083963888 cites W2326508838 @default.
• W2083963888 cites W2419508101 @default.
• W2083963888 cites W2429887863 @default.
• W2083963888 cites W2469805673 @default.
• W2083963888 cites W2475261460 @default.
• W2083963888 cites W2585382523 @default.
• W2083963888 cites W4231309718 @default.
• W2083963888 cites W4245244523 @default.
• W2083963888 cites W4249397633 @default.
• W2083963888 doi "https://doi.org/10.1002/clc.4960211208" @default.
• W2083963888 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6656245" @default.
• W2083963888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9853182" @default.
• W2083963888 hasPublicationYear "1998" @default.
• W2083963888 type Work @default.
• W2083963888 sameAs 2083963888 @default.
• W2083963888 citedByCount "9" @default.
• W2083963888 countsByYear W20839638882012 @default.
• W2083963888 countsByYear W20839638882021 @default.
• W2083963888 crossrefType "journal-article" @default.
• W2083963888 hasAuthorship W2083963888A5020150758 @default.
• W2083963888 hasAuthorship W2083963888A5065161269 @default.
• W2083963888 hasAuthorship W2083963888A5065605818 @default.
• W2083963888 hasAuthorship W2083963888A5075323311 @default.
• W2083963888 hasBestOaLocation W20839638882 @default.
• W2083963888 hasConcept C126322002 @default.
• W2083963888 hasConcept C164705383 @default.
• W2083963888 hasConcept C27016395 @default.
• W2083963888 hasConcept C2776525901 @default.
• W2083963888 hasConcept C2777880890 @default.
• W2083963888 hasConcept C2778198053 @default.
• W2083963888 hasConcept C2778742482 @default.
• W2083963888 hasConcept C2778949068 @default.
• W2083963888 hasConcept C2779611605 @default.
• W2083963888 hasConcept C71924100 @default.
• W2083963888 hasConcept C78085059 @default.
• W2083963888 hasConcept C84393581 @default.
• W2083963888 hasConceptScore W2083963888C126322002 @default.
• W2083963888 hasConceptScore W2083963888C164705383 @default.
• W2083963888 hasConceptScore W2083963888C27016395 @default.
• W2083963888 hasConceptScore W2083963888C2776525901 @default.
• W2083963888 hasConceptScore W2083963888C2777880890 @default.
• W2083963888 hasConceptScore W2083963888C2778198053 @default.
• W2083963888 hasConceptScore W2083963888C2778742482 @default.
• W2083963888 hasConceptScore W2083963888C2778949068 @default.
• W2083963888 hasConceptScore W2083963888C2779611605 @default.
• W2083963888 hasConceptScore W2083963888C71924100 @default.
• W2083963888 hasConceptScore W2083963888C78085059 @default.
• W2083963888 hasConceptScore W2083963888C84393581 @default.
• W2083963888 hasIssue "12" @default.
• W2083963888 hasLocation W20839638881 @default.
• W2083963888 hasLocation W20839638882 @default.
• W2083963888 hasLocation W20839638883 @default.
• W2083963888 hasLocation W20839638884 @default.
• W2083963888 hasOpenAccess W2083963888 @default.
• W2083963888 hasPrimaryLocation W20839638881 @default.
• W2083963888 hasRelatedWork W2020048076 @default.
• W2083963888 hasRelatedWork W2052242574 @default.
• W2083963888 hasRelatedWork W2054690540 @default.
• W2083963888 hasRelatedWork W2083963888 @default.

• next